AArtificial intelligence Read More Novo Nordisk partners with OpenAI as AI drug discovery hopes mount April 14, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
HHealthcare Read More Less than 20% of patients in Japan interested in new Alzheimer’s drugs received oneApril 9, 2026 Less than 20% of people who showed interest in taking new medications for Alzheimer’s disease went on to…
MMedication Read More FDA declines to issue specific guidance on drug importation by AFPsApril 6, 2026 The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed…
MMedication Read More Trump sets 100% tariffs on prescription drugs from companies that have not reached a deal with him to lower pricesApril 4, 2026 President Donald Trump has set 100 percent tariffs on prescription drugs from overseas companies that have not reached…
BBusiness Read More US President Donald Trump puts 100pc tariff on some pharmaceuticalsApril 2, 2026 Donald Trump has pulled the trigger on a longstanding threat to impose a 100 per cent tariff on…
MMedication Read More All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weightApril 2, 2026 G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…
HHealthcare Read More Health care giants are trimming jobs, not driving employment growthMarch 30, 2026 Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
MMedication Read More ADHD medication in short supply in Japan as demand soarsMarch 30, 2026 Since last fall, Concerta, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD), has been in short…
HHealthcare Read More Eli Lilly reaches deal to bring AI-developed drugs to global marketMarch 29, 2026 A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21,…
HHealth Read More Gut immune responses found to trigger brain inflammation in MSMarch 28, 2026 Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the brain and…
MMedication Read More FDA approves new ‘Wegovy HD’ with triple the dosage of the semaglutide medicationMarch 25, 2026 The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection.…
HHealthcare Read More Middle East war forces pharmaceutical companies to reroute critical medicines to ensure Australian supplyMarch 21, 2026 The escalating war in the Middle East has forced major pharmaceutical companies to rapidly divert critical medicines away…